ADBALYA
Live / Allowed — Published for opposition (as of 15 Sept 2026)
What this means for you
Approved and waiting on proof of use. It will register unless the applicant drops it, and its 14 Mar 2025 filing date already counts against anyone who files later.
Record
- Serial number
- 99084951
- Mark type
- Stylized text
- Filed
- 14 Mar 2025
- Published for opposition
- 15 Sept 2026
- Attorney of record
- Leonid Rakitin
Goods and services
- Class 005 — Pharmaceuticals: Pharmaceutical preparations for use in oncology; Pharmaceutical preparations for the treatment of diseases and disorders of the cardiovascular, renal, metabolic, respiratory, nervous, dermatological, neurological, gastrointestinal, and immune systems; Vaccines
Owner
- AstraZeneca AB, Södertälje, SE
- AstraZeneca AB, Södertälje, SE
Prosecution history
- 15 Sept 2026 — OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
- 15 Sept 2026 — PUBLISHED FOR OPPOSITION
- 09 Sept 2026 — NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
- 19 Aug 2026 — APPROVED FOR PUB - PRINCIPAL REGISTER
- 11 Aug 2026 — TEAS/EMAIL CORRESPONDENCE ENTERED
- 11 Aug 2026 — CORRESPONDENCE RECEIVED IN LAW OFFICE
- 11 Aug 2026 — TEAS RESPONSE TO OFFICE ACTION RECEIVED
- 06 Aug 2026 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 06 Aug 2026 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 06 Aug 2026 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 14 May 2026 — NOTIFICATION OF NON-FINAL ACTION E-MAILED
- 14 May 2026 — NON-FINAL ACTION E-MAILED
- 14 May 2026 — NON-FINAL ACTION WRITTEN
- 15 Apr 2026 — EXAMINER'S AMENDMENT ENTERED
- 15 Apr 2026 — NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED